Author:
Carrasco Joao,Pietsch Georg-Alexander,Nicolas Marie-Pierre,Koerber Cecile,Bennison Craig,Yoon Jisu
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference53 articles.
1. Wong WL, Su X, Li X, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2(2):e106–16.
2. Lucentis® [prescribing information]. https://www.gene.com/download/pdf/lucentis_prescribing.pdf. Accessed June 28, 2018.
3. Eylea® [prescribing information]. https://www.regeneron.com/sites/default/files/EYLEA_FPI.pdf. Accessed June 28, 2019.
4. Brown DM, Kaiser PK, Michels M, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med. 2006;355(14):1432–44.
5. Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355(14):1419–31.
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献